TBK軟膏による白癬の治験
スポンサーリンク
概要
- 論文の詳細を見る
The therapeutic effect of antifungal agent, 3-(p-methylbenzylideneamino)-4-phenylthiazoline-2-thione referred as TBK hereafter, was clinically tested on some kinds of tinea. TBK preparations, in a form of carbowax ointment containing one (TBK I) or two (TBK II) percent, was applied. Of 30 subjects tested, there were 19 Tinea cruris, 10 T. interdigitalis and 14 T. pedis. TBK I was applied in 10 subjects and TBK II in 7. In the rest, both preparations were used—different lesions of same individual—for comparison of efficacy according to the concentrations. The therapeutic effects of TBK I and TBK II were 70% and 89% for T. cruris, 71% and 100% for T. interdigitalis, and 17% and 33% for T. pedis, respectively. As to side effects, contact dermatitis was observed only in a patient with T. cruris treated by TBK II.
- 日本皮膚科学会西部支部の論文
日本皮膚科学会西部支部 | 論文
- 症例 Toxic Epidermal Necrolysis(TEN)型皮疹を呈したDrug-Induced Hypersensitivity Syndrome(DIHS)の1例
- Hydrocortisone17-Butyrate外用剤(Locoid)の使用経験--とくに弗素化ステロイド長期外用例について
- 多彩な皮膚病変を呈した慢性GVHDの1例
- Lupus Erythematosus Profundus に伴って筋の線維化を認めた1例
- 尿素外用剤塗布後の快適性に関する調査